| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |